AKT1 and breast cancer: However, our research extends this understanding by explicitly linking EPHA2 to the AKT/PI3K signaling pathway and demonstrating that its inhibition can enhance pyroptotic responses in breast cancer cells, a relationship that has not been thoroughly explored in prior research.